BofA Securities Upgrades Vir Biotechnology (VIR) to Buy, 'Underappreciated HDV opportunity, TCEs essentially free'
Go back to BofA Securities Upgrades Vir Biotechnology (VIR) to Buy, 'Underappreciated HDV opportunity, TCEs essentially free'| (NASDAQ: VIR) | Delayed: 9.24 +0.24 (2.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.00 | 52 Week High | $ | |||
| Open | $9.00 | 52 Week Low | $ | |||
| Day High | $9.27 | P/E | N/A | |||
| Day Low | $8.80 | EPS | $ | |||
| Volume | 1,016,285 | |||||

